Federal Circuit Reverses ScriptPro Invalidity Ruling

Aug 8, 2014

Reading Time : 1 min

In 2012, District Judge Carlos Murguia held that U.S. Patent No. 6,910,601 was invalid for lack of an adequate written description. Specifically, Judge Murguia found that the ‘601 patent ­ which involves a robotic prescription pill dispensing system ­ has a specification that described a machine that needed “sensors” to work, whereas the claims at issue did not recite “sensors.”

The Federal Circuit disagreed that sensors were required and held, “[t]here is no sufficiently clear language in the specification that limits the invention to a collating unit with the (slot checking) sensors.” The panel found that the portions of the patent relied on by the district court merely describe what “the sensor does when it is used, not that it must be used.” For example, the specification describes the sensor as a “security feature” to “determine if any container is located in the [holding] area.” This, the panel found, suggests sensors are an optional component. Finding an ambiguity within the specification, the panel concluded that summary judgment was inappropriate.

Additionally, the Federal Court pointed out that the original claims, before amendment following reexamination, did not require sensors. The court stated “[w]hen a specification is ambiguous about which of several features are stand­alone inventions, the original claims can help resolve the ambiguity, though even original claims may be insufficient as descriptions or be insufficiently supported by the rest of the specification.”

ScriptPro, LLC et al., v. Innovation Associates, Inc., No. 2013­1561, (Fed. Cir. Aug. 6, 2014) [R. Taranto].

Share This Insight

Categories

Previous Entries

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.